Chronoscale announces agreements bringing contracted run-rate revenue to $1 billion and sale of Ekso Bionics business unit
CHRN•Chronoscale said contract extensions and a new agreement with AI infrastructure customers provide for $1 billion in annualized run-rate revenue by Q3 2027. The company also announced the sale of its Ekso Bionics business unit.
1. Agreements and sale
Chronoscale said it signed a contract extension and a new agreement with AI infrastructure customers, with the agreements providing for $1 billion in annualized run-rate revenue by Q3 2027. It also announced the sale of its Ekso Bionics business unit.
